يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Mennitto A."', وقت الاستعلام: 0.83s تنقيح النتائج
  1. 1
    دورية أكاديمية
    GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study

    المؤلفون: F. Pietrantonio, C. Maggi, M. Niger, A. Mennitto, F. de Braud, R. Berenato, M. Caporale, M. Milione, F. Perrone, E. Tamborini, D. Baratti, S. Kusamura, L. Mariani, A. Gloghini, I. Bossi, G. Settanni, A. Busico, P. F. Bagnoli, M. Di Bartolomeo, M. Deraco

    المساهمون: F. Pietrantonio, R. Berenato, C. Maggi, M. Caporale, M. Milione, F. Perrone, E. Tamborini, D. Baratti, S. Kusamura, L. Mariani, M. Niger, A. Mennitto, A. Gloghini, I. Bossi, G. Settanni, A. Busico, P.F. Bagnoli, M. Di Bartolomeo, M. Deraco, F. de Braud

    مصطلحات موضوعية: appendiceal cancer, bevacizumab, GNAS, metronomic capecitabine, next-generation sequencing, peritoneal pseudomyxoma, medicine (all), biochemistry, genetics and molecular biology (all), Settore MED/06 - Oncologia Medica

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27154293; info:eu-repo/semantics/altIdentifier/wos/WOS:000375475200003; volume:14; issue:1; numberofpages:7; journal:JOURNAL OF TRANSLATIONAL MEDICINE; http://hdl.handle.net/2434/442322Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84965062428

    الإتاحة: https://doi.org/10.1186/s12967-016-0877-xTest
    http://hdl.handle.net/2434/442322Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Clinical outcome of renal cancer patients who early interrupted immunotherapy due to serious immune-related adverse events. Meet-Uro 13 trial on behalf of the MeetUro investigators.

    المؤلفون: Stellato, Marco, Procopio, Giuseppe, De Giorgi, Ugo, Maruzzo, Marco, Bimbatti, Davide, Mennitto, Alessia, Sbrana, Andrea, Roviello, Giandomenico, Casadei, Chiara, Sepe, Pierangela, Pignata, Sandro, Santini, Daniele

    المصدر: Journal of Translational Medicine; 8/3/2021, Vol. 19 Issue 1, p1-6, 6p

    مصطلحات موضوعية: DRUG side effects, TREATMENT effectiveness, RENAL cancer, CANCER prognosis, CANCER patients

    مصطلحات جغرافية: CHICAGO (Ill.)

    النص الكامل

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.

    المؤلفون: Pietrantonio, Filippo, Berenato, Rosa, Maggi, Claudia, Caporale, Marta, Milione, Massimo, Perrone, Federica, Tamborini, Elena, Baratti, Dario, Kusamura, Shigeki, Mariani, Luigi, Niger, Monica, Mennitto, Alessia, Gloghini, Annunziata, Bossi, Ilaria, Settanni, Giulio, Busico, Adele, Bagnoli, Pietro Francesco, Di Bartolomeo, Maria, Deraco, Marcello, de Braud, Filippo

    المصدر: Journal of Translational Medicine; 5/6/2016, Vol. 14, p1-7, 7p

    مصطلحات موضوعية: PERITONEAL dialysis, APPENDICITIS diagnosis, BEVACIZUMAB, NUCLEOTIDE sequencing, PATIENT compliance, CANCER relapse, CLINICAL trials, COMPARATIVE studies, DRUG administration, HUMAN genome, RESEARCH methodology, MEDICAL cooperation, MEDICAL research, MEMBRANE proteins, GENETIC mutation, PROGNOSIS, RESEARCH, CHROMOGRANINS, PERITONEUM tumors, EVALUATION research, TREATMENT effectiveness, KAPLAN-Meier estimator

    النص الكامل

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث